SEFVIR 250MG INJ

Product Description

SEFVIR 250MG INJ is a premium-quality antiviral injection formulated with Acyclovir 250mg, widely prescribed for the treatment of herpes simplex infections, shingles (herpes zoster), chickenpox, and genital herpes. This injectable formulation is designed for intravenous administration, ensuring rapid onset of action in severe viral infections, especially in hospitalized or immunocompromised patients.

Manufactured under strict WHO-GMP guidelines, SEFVIR 250MG INJ is ideal for hospital supply chains, critical care units, and bulk pharmaceutical procurement across India and global markets.

Key Benefits:

• Contains Acyclovir 250mg, a potent antiviral agent

• Fast-acting solution for life-threatening viral infections

• Ensures high bioavailability and targeted action

• Compliant with international quality standards

Usage/Application:

• Treatment of herpes simplex virus (HSV) infections

• Management of herpes zoster (shingles) and varicella (chickenpox)

• Used in ICU settings for immunocompromised patients

Why Choose SEFVIR 250MG INJ?

• Reliable therapeutic response in acute viral cases

• Suitable for bulk orders, tenders, and hospital supply contracts

• Backed by efficient logistics and consistent stock availability